Endometrial Cancer

Screening, Diagnosis, and Surgical Staging
  • Annekathryn GoodmanEmail author
  • Barbara Goff
Part of the Current Clinical Oncology book series (CCO)


Through case studies, the authors point out environmental and hereditary factors that contribute to increased risk of developing endometrial cancer and how to apply screening modalities in pre- and postmenopausal women. Attention is drawn to certain anatomic abnormalities that prevent vaginal bleeding – the most common symptom related to cancer. Diagnostic tests that are available to pursue various aspects of the diagnosis in a sequential fashion are described, culminating in the endometrial biopsy. Recommendations for screening and diagnosis in the asymptomatic as well as the symptomatic patients are summarized. Surgical staging represents the final event in the diagnostic workup. Instances when such staging can be modified to deal with various comorbidities are delineated.


Endometrial cancer Heredity Screening Endometrial biopsy Surgical staging 


  1. 1.
    Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. Cancer Statistics 2006. CA Cancer J Clin 2006; 56:106–130.PubMedCrossRefGoogle Scholar
  2. 2.
    Hale GE, Hughes CL, Cline JM. Endometrial cancer: hormonal factors, the perimenopausal “window at risk”, and isoflavones. J Clin Endocrinol Metab 2002; 87:3.PubMedCrossRefGoogle Scholar
  3. 3.
    Coulam CB, Anneger JF, Kranz JS. Chronic anovulation syndrome and associated neoplasia. Obstet Gynecol 1983; 61:403.PubMedGoogle Scholar
  4. 4.
    Azziz R, Woods KS, Reyna R, et al The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004; 89:2745.PubMedCrossRefGoogle Scholar
  5. 5.
    Schlechte J, Sherman B, Halmi N, et al. Prolactin-secreting pituitary tumors in amenorrheic women: a comparative study. Endocr Rev 1980; 1:295.PubMedCrossRefGoogle Scholar
  6. 6.
    Outwater EK, Wagner BJ, Mannion C, et al Sex cord-stromal and steroid cell tumors of the ovary. Radiographics 1998; 18:1523.PubMedGoogle Scholar
  7. 7.
    Siiteri PK. Adipose tissue as a source of hormones. Am J Clin Nutr 1987; 45:277.PubMedGoogle Scholar
  8. 8.
    Persson I, Adami H-O, Bergkvist L, et al Risk of endometrial cancer after treatment with estrogens alone or in conjunction with progestogens: results of a prospective study. BMJ 1989; 298:147.PubMedCrossRefGoogle Scholar
  9. 9.
    Zumoff B, Fishman J, Gallagher TF, Hellman L. Estradiol metabolism in cirrhosis.J Clin Invest 1968; 47(1):20–25.PubMedCrossRefGoogle Scholar
  10. 10.
    Cohen I. Endometrial pathologies associated with postmenopausal tamoxifen treatment. Gynecol Oncol 2004; 94:256.PubMedCrossRefGoogle Scholar
  11. 11.
    Suh-Burgmann EJ, Goodman A. Surveillance for endometrial cancer in women receiving tamoxifen. Ann Intern Med 1999; 131:127–135.PubMedGoogle Scholar
  12. 12.
    Fisher B, Constantino JP, Redmond CK, Fisher ER, Wickerham DL, Cronin WM. Endometrial cancer in tamoxifen treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 1994; 86:527–537.PubMedCrossRefGoogle Scholar
  13. 13.
    ACOG Commitee Opinior Number 232 April 2000-Tomoxifen and Endometrial Cancer.Google Scholar
  14. 14.
    Ollikainen M, Abdel-Rahman WM, Moisio AL, et al Molecular analysis of familial endometrial carcinoma: a manifestation of hereditary nonpolyposis colorectal cancer or a separate syndrome? J Clin Oncol 2005; 23:4609.PubMedCrossRefGoogle Scholar
  15. 15.
    Schmeler KM, Lynch HT, Chen L-M, et al. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch Syndrome. N Eng J Med 2006; 354:261–269.CrossRefGoogle Scholar
  16. 16.
    Levine DA, Lin O, Barakat RR, et al. Risk of endometrial carcinoma associated with BRCA mutation. Gynecol Oncol 2001; 80:395.PubMedCrossRefGoogle Scholar
  17. 17.
    Kleinerman RA, Boice JD, Storm HH, et al. Second primary cancer after treatment for cervical cancer. Cancer 1995; 76:442–452.PubMedCrossRefGoogle Scholar
  18. 18.
    Anderson B. Diagnosis of endometrial cancer. Clin Obstet Gynecol 1986; 13:739–750.Google Scholar
  19. 19.
    Pellerin GP, Finan MA. Endometrial cancer in women 45 years of age or younger: a clinicopathological analysis. Am J Obstet Gynecol 2005; 193:1640.PubMedCrossRefGoogle Scholar
  20. 20.
    Cherkis RC, Patten SF, Jr, Andrews TJ, et al. Significance of normal endometrial cells detected by cervical cytology. Obstet Gynecol 1988; 71:242.PubMedGoogle Scholar
  21. 21.
    Cherkis RC, Patten SF, Jr, Dickinson JC, et al Significance of atypical endometrial cells detected by cervical cytology. Obstet Gynecol 1987; 69:786.PubMedGoogle Scholar
  22. 22.
    DuBeshter B, Warshal DP, Angel C, et al. Endometrial carcinoma: the relevance of cervical cytology. Obstet Gynecol 1991; 77:458.PubMedGoogle Scholar
  23. 23.
    Chang A, Sandweiss L, Bose S. Cytologically benign endometrial cells in the papanicolaou smears of postmenopausal women. Gynecol Oncol 2001; 80:37.PubMedCrossRefGoogle Scholar
  24. 24.
    Clark TJ, Mann CH, Shah N, Khan KS, Song F, Gupta JK. Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial cancer: a systematic quantitative review. BJOG: An Int J Obstet & Gynaecol 2002; 109:313CrossRefGoogle Scholar
  25. 25.
    Karlsson B, Granberg S, Wikland M, et al Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding – a Nordic multicenter study. Am J Obstet Gynecol 1995; 172:1488.PubMedCrossRefGoogle Scholar
  26. 26.
    Decensi A, Fontana V, Bruno S, Gustavino C, Gatteschi B, Costa A. Effect of tamoxifen on endometrial proliferation. J Clin Oncol 1996; 14:434–440.PubMedGoogle Scholar
  27. 27.
    Love CDB, Muir BB, Scrimgeour JB, et al Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening. J Clin Oncol 1999; 17:2050.PubMedGoogle Scholar
  28. 28.
    Schwartz LB, Snyder J, Horan C, Porges RF, Nachtigall LE, Goldstein SR. The use of transvaginal ultrasound and saline infusion sonohysterography for the evaluation of asymptomatic postmenopausal breast cancer patients on tamoxifen. Ultrasound Obstet Gynecol 1998; 11:48–53.PubMedCrossRefGoogle Scholar
  29. 29.
    Manfredi R, Gui B, Maresca G, Fanfaui F, Bonomo L. Endometrial cancer: magnetic resonance imaging. Abdom Imaging 2005; 30:626–636.PubMedCrossRefGoogle Scholar
  30. 30.
    Novak E. A suction-curet apparatus endometrial biopsy. JAMA 1935; 104:1497–1498.CrossRefGoogle Scholar
  31. 31.
    Behnamfar F, Khamehchian T, Mazoochi T, Fahiminejad T. Diagnostic value of endometrial sampling with pipelle suction curettage for identifying endometrial lesions in patients with abnormal uterine bleeding. J Res Med Sci 2004; 3:21–23.Google Scholar
  32. 32.
    Goldberg GL, Tsalacopoulos G, Davey DA. A comparison of endometrial sampling with the Accurette and Vabra aspirator and uterine curettage. S Afr Med J 1982; 61:114–116.PubMedGoogle Scholar
  33. 33.
    International Federation of Gynecology and Obstetrics. Annual report on the results of treatment in gynecologic cancer. Int J Gynecol Obstet 1989; 28:189–190.CrossRefGoogle Scholar
  34. 34.
    Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. Cancer 1987; 60:2035–2041.PubMedCrossRefGoogle Scholar
  35. 35.
    Aquino-Parsons C, Lim P, Wong F, Mildenberger M. Papillary serous and clear cell carcinoma limited to endometrial curettings in FIGO stage Ia and Ib endometrial adenocarcinoma: treatment implications. Gynecol Oncol 1998; 71:83–86.PubMedCrossRefGoogle Scholar
  36. 36.
    Goff BA, Rice LW. Assessment of depth of myometrial invasion in endometrial adenocarcinoma. Gynecol Oncol 1990; 38:46–48.PubMedCrossRefGoogle Scholar
  37. 37.
    Acog Partice bulleten, number 65, August 2005. Management of Endometrial CancerGoogle Scholar
  38. 38.
    Kilgore LC, Partridge EE, Alvarez RD, Austin JM, Shingleton HM, Noojian F, III, et al. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 1995; 56:29–33.PubMedCrossRefGoogle Scholar
  39. 39.
    Fowler JM. Laparoscopic staging of endometrial cancer. Clin Obstet Gynecol 1996; 39:669.PubMedCrossRefGoogle Scholar
  40. 40.
    Soliman PT, Slomovitz BM, Broaddus RR, et al. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases. Gynecol Oncol 2004; 94:456.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press, a part of Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Division of Gynecologic OncologyGillette Center for Women’s Cancers Massachusetts General HospitalBoston

Personalised recommendations